The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
The National Cancer Institute: cancer drug discovery and development program.
|
|---|---|
| Published in |
Seminars in oncology, December 1992
|
| Pubmed ID | |
| Authors |
M R Grever, S A Schepartz, B A Chabner |
| Abstract |
The discovery and development of novel therapeutic products for the treatment of malignancy is vitally important to those physicians responsible for the management of cancer patients. A description of the ongoing efforts at the National Cancer Institute (NCI) is intended to provide insight into those complex processes necessary to accomplish this mission. An update on the NCI's revised cancer screen is accompanied by a brief summary of those new agents scheduled to be entered into clinical investigation in the near future. The tremendous potential advantages and challenges associated with the use of a molecular approach to cancer drug design are discussed. Despite the differences of opinion that may exist regarding the optimal strategies for accomplishing the mission, there is no disagreement regarding the importance of the effort to find effective new therapies for cancer patients. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 83 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 15 | 18% |
| Student > Master | 11 | 13% |
| Researcher | 7 | 8% |
| Student > Bachelor | 7 | 8% |
| Student > Doctoral Student | 4 | 5% |
| Other | 15 | 18% |
| Unknown | 26 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 20 | 24% |
| Medicine and Dentistry | 10 | 12% |
| Agricultural and Biological Sciences | 9 | 11% |
| Biochemistry, Genetics and Molecular Biology | 6 | 7% |
| Computer Science | 3 | 4% |
| Other | 3 | 4% |
| Unknown | 34 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2012.
All research outputs
#8,537,346
of 25,377,790 outputs
Outputs from Seminars in oncology
#329
of 1,053 outputs
Outputs of similar age
#13,009
of 65,174 outputs
Outputs of similar age from Seminars in oncology
#1
of 4 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,053 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 65,174 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them